RxDoctor Payments Data

Glenn Turner

Nurse Practitioner · Plant City, FLNPI 1073656203

Payments from drug & device makers

$18,316in general payments, 2019–2025

Across 875 payments — averaging $20.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$2K
  • AbbVie$2K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Novartis$1K
  • Amgen$971
  • Bristol Myers Squibb$886
  • plus $10K from 54 others

What the payments were for

  • Consulting fees$3002%
  • Food & beverage$17,91998%
  • Education$971%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.90$2,335
AbbVie(2 entities)104$1,842
Teva Pharmaceuticals USA, Inc.67$1,366
Novartis61$1,112
Amgen40$971
Bristol Myers Squibb41$886
Pfizer70$814
Eisai Inc.37$763
Neurocrine Biosciences, Inc.29$605
Johnson & Johnson(2 entities)18$576
Upsher-smith Laboratories LLC22$550
Biogen15$534
Neurelis, Inc.26$528
EMD Serono, Inc.21$467
Kyowa Kirin, Inc.22$433
Lilly USA, LLC15$294
Lundbeck LLC12$283
Scilex Pharmaceuticals Inc.13$272
SK Life Science, Inc.10$261
Biohaven Pharmaceuticals, Inc.11$260
Collegium Pharmaceutical, Inc.16$257
Aquestive Therapeutics, Inc.10$206
Sunovion Pharmaceuticals Inc.11$206
Biohaven Pharmaceutical Holding Company Ltd.10$206
Avanir Pharmaceuticals, Inc.7$187
Otsuka America Pharmaceutical, Inc.7$174
Tanabe Pharma America, Inc.6$159
Amneal Pharmaceuticals LLC8$133
Argenx US, Inc.5$129
Jazz Pharmaceuticals Inc.5$122
Sanofi5$118
E.r. Squibb & Sons, L.L.C.2$105
Acorda Therapeutics, Inc6$105
Sumitomo Pharma America, Inc.5$91
AstraZeneca4$89
CSL Behring3$80
Acadia Pharmaceuticals Inc4$79
Axsome Therapeutics, Inc.4$77
Takeda Pharmaceuticals U.S.A., Inc.3$68
Corium, LLC3$54
Novo Nordisk2$41
Averitas Pharma Inc.2$36
Alnylam Pharmaceuticals Inc.2$35
Livanova USA, Inc.1$34
GE HealthCare2$32
C2n Diagnostics, LLC1$31
Merz Pharmaceuticals, LLC1$30
Supernus Pharmaceuticals, Inc.2$25
Harmony Biosciences LLC1$25
Genentech USA, Inc.1$25
Banner Life Sciences, LLC1$24
Almatica Pharma LLC1$21
Mallinckrodt Hospital Products Inc.1$21
Impel Pharmaceuticals LLC1$19
Merck1$19
Idorsia Pharmaceuticals US Inc1$17
Arbor Pharmaceuticals, Inc.1$17
Xeris Pharmaceuticals, Inc.1$16
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$14
Azurity Pharmaceuticals, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,316 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$48,068
Medicare patients
217
Services billed
520

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
QuliptaAtogepant94$142,482
Austedo XrDeutetrabenazine11$140,061
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5014$135,480
UbrelvyUbrogepant73$125,983
BotoxOnabotulinumtoxina64$81,926
Aimovig AutoinjectorErenumab-Aooe84$76,292
Nurtec OdtRimegepant Sulfate26$47,161
TopamaxTopiramate11$33,975
RexultiBrexpiprazole11$28,113
AptiomEslicarbazepine Acetate13$24,769
Emgality PenGalcanezumab-Gnlm20$22,528
ZtlidoLidocaine28$22,426
NeuproRotigotine18$18,861
Ajovy AutoinjectorFremanezumab-Vfrm18$18,139
Lacosamide72$12,135

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieQulipta, Ubrelvy, Botox, Linzess$1,842$358,209242 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr$1,366$140,06111 claims
Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid$68$135,48014 claims
PfizerNurtec Odt$814$47,16126 claims
Otsuka America Pharmaceutical, Inc.Rexulti$174$28,11311 claims
Sunovion Pharmaceuticals Inc.Aptiom$206$24,76913 claims
Scilex Pharmaceuticals Inc.Ztlido$272$22,42628 claims
UCB, Inc.Neupro$2,335$18,86118 claims
MerckBelsomra$19$8,79115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Plant City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →